Masoud Azodi, MD
Masoud Azodi, MD
Associate Professor
Yale University School of Medicine
Dept. of OB/GYN
333 Cedar Street
New Haven,
CT
USA
06520
Papers:
167 - Poster Session A
Weekly ixabepilone with or without concurrent bevacizumab in the treatment of platinum/taxane-resistant endometrial and ovarian cancers: an institutional experience
241 - Poster Session A
Solitomab, an EpCAM/CD3 bispecific antibody (BiTE®), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo